Paper28601065
Mazes of Nrf2 Regulation.
Zenkov NK and 5 others. Biochemistry (Mosc), 2017. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Mazes of Nrf2 Regulation. Papers, record 28601065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28601065
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epigenesis, Genetic | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Neoplasm Proteins | Major topic |
| Oxidative Stress | Major topic |
| Transcription, Genetic | Major topic |
| Animals | |
| Autophagy | |
| Humans | |
| Kelch-Like ECH-Associated Protein 1 | |
| Neoplasms | |
| Proteasome Endopeptidase Complex | |
| Radiation Tolerance | |
| Ubiquitination |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40427478 | Targeting Lysosomal Dysfunction and Oxidative Stress in Age-Related Macular Degeneration. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427478 | PubMed |
| 39857448 | Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/39857448 | PubMed |
| 39444605 | Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39444605 | PubMed |
| 39309822 | The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs. | Heliyon | 2024 | https://conductscience.org/library/papers/39309822 | PubMed |
| 38732142 | Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732142 | PubMed |
| 38539804 | Nutrigenomics of Natural Antioxidants in Broilers. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38539804 | PubMed |
| 38340195 | Effect of Inducers and Inhibitors of the Keap1/Nrf2/ARE System on the Viability and Functional Activity of Model Neuronal-Like and Glial Cells. | Bull Exp Biol Med | 2024 | https://conductscience.org/library/papers/38340195 | PubMed |
| 38255971 | Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255971 | PubMed |
| 36969871 | Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36969871 | PubMed |
| 36670894 | Neuroprotective Effects of Pulicaria incisa Infusion on Human Neuroblastoma Cells and Hippocampal Neurons. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36670894 | PubMed |
| 36033575 | Proanthocyanidins Activate Nrf2/ARE Signaling Pathway in Intestinal Epithelial Cells by Inhibiting the Ubiquitinated Degradation of Nrf2. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36033575 | PubMed |
| 35986803 | The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury. | Apoptosis | 2022 | https://conductscience.org/library/papers/35986803 | PubMed |
| 35368867 | Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35368867 | PubMed |
| 34887759 | Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34887759 | PubMed |
| 34732330 | Nrf2/Keap1/ARE signaling: Towards specific regulation. | Life Sci | 2022 | https://conductscience.org/library/papers/34732330 | PubMed |
| 34599229 | Increased oxidative stress contributes to enhance brain amyloidogenesis and blunts energy metabolism in sucrose-fed rat: effect of AMPK activation. | Sci Rep | 2021 | https://conductscience.org/library/papers/34599229 | PubMed |
| 34093961 | The Oral Delivery of Water-Soluble Phenol TS-13 Ameliorates Granuloma Formation in an In Vivo Model of Tuberculous Granulomatous Inflammation. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34093961 | PubMed |
| 34063933 | Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34063933 | PubMed |
| 31752195 | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31752195 | PubMed |
| 30040046 | Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity. | Radiat Res | 2018 | https://conductscience.org/library/papers/30040046 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28601065
GET https://conductscience.org/api/papers/v1/28601065/authors